Glenmede Trust’s Organon & Co OGN Stock Holding History

Glenmede Trust’s Portfolio OGN Stock Details OGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-39,475	Closed	-$742K	–	1402
2024 Q1	$742K	Sell	39,475 -1,035	-3%	-$17.8K	﹤0.01%	792
2023 Q4	$584K	Sell	40,510 -17,405	-30%	-$237K	﹤0.01%	848
2023 Q3	$1.01M	Buy	57,915 +43,469	+301%	+$906K	0.01%	656
2023 Q2	$340K	Hold	14,446	–	–	﹤0.01%	950
2023 Q1	$340K	Sell	14,446 -237	-2%	-$6.36K	﹤0.01%	955
2022 Q4	$410K	Sell	14,683 -3,072	-17%	-$78.5K	﹤0.01%	886
2022 Q3	$415K	Sell	17,755 -2,367	-12%	-$71.5K	﹤0.01%	857
2022 Q2	$678K	Sell	20,122 -15,803	-44%	-$554K	﹤0.01%	772
2022 Q1	$1.25M	Sell	35,925 -29,783	-45%	-$1.02M	0.01%	653
2021 Q4	$2M	Sell	65,708 -9,270	-12%	-$302K	0.01%	566
2021 Q3	$2.46M	Sell	74,978 -2,641	-3%	-$84.5K	0.01%	512
2021 Q2	$2.35M	Buy	+77,619	New	+$2.56M	0.01%	508

Other funds holding OGN

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Nordea Investment Management Stockholm, Sweden $123B AUM 38.85% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return

SPC

Slate Path Capital New York $7.22B AUM 110.75% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

SSM

Sound Shore Management Greenwich, Connecticut $3.25B AUM 28.47% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Glenmede Trust's OGN Position: Q2 2024 in Review

Glenmede Trust sold out of Organon & Co (OGN) in Q2 2024, closing a stake of 39,475 shares — an estimated $742K sold.

Glenmede Trust first reported a position in OGN in Q2 2021 and held it in 12 quarters. The position peaked at $2.46M in Q3 2021. 724 funds tracked by Wall St. Rank hold OGN as of Q2 2024.

Glenmede Trust reported no remaining Organon & Co position as of Q2 2024 after selling out during the quarter.
Glenmede Trust sold 39,475 Organon & Co shares in Q2 2024, an estimated $742K.
Glenmede Trust first reported a position in Organon & Co in Q2 2021 and held it in 12 quarters.
Glenmede Trust's Organon & Co position peaked at $2.46M in Q3 2021.
724 funds tracked by Wall St. Rank held Organon & Co as of Q2 2024.

Based on Glenmede Trust's 13F filing for Q2 2024, filed 14 Aug 2024.